M. Molina-Molina (Barcelona Barcelona, Spain), C. Vancheri (Catania, Italy), G. Margaritopoulos (Kavala, Greece)
Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?
M. Moreno, S. Castillo, B. Fernández, V. Posadas, O. Benavent, A. Escribano (Valencia, Spain)
|   |
Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases
D. Visca, A. De Lauretis, A. Wells, A. Montgomery, T. Maher, V. Alfieri, A. A. Chetta, S. Valente, E. Renzoni (London, United Kingdom; Parma, Roma, Italy)
| |
BAL findings in desquamative interstitial pneumonia (DIP) and other idiopathic interstitial pneumonia (IIP)
C. Ravaglia, S. Tomassetti, G. Casoni, C. Gurioli, C. Gurioli, M. Romagnoli, S. Piciucchi, A. Dubini, M. Chilosi, V. Poletti (Forlì, Verona, Italy)
| |
Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
N. Affara, A. Refaat, M. Gawish (Zagazig, Egypt)
| |
Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases
M. Sterclova, P. Paluch, K. Heinzelmann, O. Eickelberg, M. Vasakova (Prague, Czech Republic; Munich, Germany)
| |
Usefulness of a myositis antibody immunoblot in diagnosis of connective tissue disease (CTD) related interstitial lung disease (ILD)
J. Robson, A. McHugh, S. Savic, P. Beirne (Leeds, United Kingdom)
| |
Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis
K. Kataoka, H. Taniguchi, Y. Kondoh, T. Kimura, T. Matsuda, T. Yokoyama, Y. Yamano, Y. Nakahara, M. Yagi (Seto, Japan)
| |
Three cases of idiopathic pleuroparenchymal fibroelastosis associated with amyotrophic lateral sclerosis
S. Akagawa, R. Sato, K. Okuda, K. Koyama, M. Shimada, K. Masuda, H. Matsui, K. Ohta (Kiyose-shi, Japan)
| |
Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort
M. J. Kohlhaeufl, H. Ingerl, M. Bachnik (Gerlingen-Stuttgart, Germany)
| |
Cryptogenic organising pneumonia focusing on its prognostic determinants
R. Slivka, P. Janik, R. Holecko (Vysne Hagy, Slovakia)
| |
Extrapulmonary involvement in sarcoidosis patients
S. Güngör, M. Yalçinsoy, E. Usta Bülbül, B. B. Afsar Dönmez, O. Akkan, E. Akkütük Öngel, E. Akkaya (Istanbul, Adana, Turkey)
| |
Measurement of alveolar nitric oxide in IPF patients and in healthy controls
E. Bouros, P. Ntolios, A. Tzouvelekis, P. Boglou, K. Kaltsas, P. Steiropoulos, M. Froudarakis, E. Paraskakis, D. Bouros (Alexandroupolis, Greece)
| |
Pulmonary distribution and localization of pirfenidone in animal models of IPF by MS/MS
I. Fernandez, N. Sun, M. Wei, M. Aichler, A. Walch, O. Eickelberg (Munich, Neuherberg, Germany)
| |
Sulforaphane attenuates lung fibrosis in bleomycin-induced pulmonary fibrosis via inhibition of TGF-beta/Smad signaling
S. Y. Kyung, Y. J. Kim, S. M. Lee, S. M. Kang, S. P. Lee, J. W. Park, S. H. Jeong (Incheon, Republic Of Korea)
| |
The effect of pirfenidone with patients with idiopathic pulmonary fibrosis in one university hospital
Y. Ichimura, K. Tsushima, T. Matsumura, A. Yokota, J. Terada, K. Iesato, S. Sakao, Y. Tada, N. Tanabe, K. Tatsumi (Chiba, Japan)
| |
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
P. Kopinski, A. Dyczek, B. Balicka-Slusarczyk, G. Przybylski, E. Wedrowska, J. Golinska, J. Chorostowska-Wynimko (Bydgoszcz, Krakow, Warszawa, Poland)
| |
Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
B. A. M. Downie, J. Shakespeare, L. Archer, R. Hastings, F. Woodhead, E. Helm, R. Hughes, D. Parr (Coventry, United Kingdom)
| |
Effect of TGF-beta on functional properties of un-stretched and stretched neonatal lung (myo)fibroblast
P. Oak, N. Jain, M. Koschlig, T. Reicherzer, H. Ehrhardt, A. Hilgendorff (Munich, Giessen, Germany)
| |
Parenchymal cell populations involved in the development of fibrosis
B. C. Heckl, I. E. Fernandez Buelvas, K. Heinzelmann, O. Eickelberg (München, Germany)
| |
Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
S. K. Kim, C. K. Park, K. H. Park, J. S. Kim, J. H. Ahn, S. S. Kwon, C. H. Kim (Seoul, Republic Of Korea)
| |